Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by N Robillard
The Absence of CD56 (NCAM) on Malignant Plasma Cells Is a Hallmark of Plasma Cell Leukemia and of a Special Subset of Multiple Myeloma
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Identification of Malignant Plasma Cell Precursors in the Bone Marrow of Multiple Myeloma.
Journal of Clinical Investigation
Medicine
Anti-Myeloma Activity of MELK Inhibitor OTS167: Effects on Drug-Resistant Myeloma Cells and Putative Myeloma Stem Cell Replenishment of Malignant Plasma Cells
Blood Cancer Journal
Oncology
Hematology
Plasma Cell Satellitism in Plasma Cell Myeloma
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Profound Impact of Sample Processing Delay on Gene Expression of Multiple Myeloma Plasma Cells
BMC Medical Genomics
Genetics
CD229 Is Expressed on the Surface of Plasma Cells Carrying an Aberrant Phenotype and Chemotherapy-Resistant Precursor Cells in Multiple Myeloma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Experimental African Trypanosome Infection Suppresses the Development of Multiple Myeloma in Mice by Inducing Intrinsic Apoptosis of Malignant Plasma Cells
Oncotarget
Oncology
Prognostic Value of CD56 Expression in Multiple Myeloma
Research in Oncology
Lymphocyte Subset Recovery and Outcome After Autologous Hematopoietic Stem Cell Transplantation for Plasma Cell Myeloma
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Detection of 13q Deletion in Multiple Myeloma Using Immunomagnetically Selected Plasma Cells
Revista Brasileira de Hematologia e Hemoterapia
